Literature DB >> 8673847

Prevalence of antibodies to human herpesviruses 6 and 7 in early infancy and age at primary infection.

C Cermelli1, G Fabio, M Montorsi, A M Sabbatini, M Portolani.   

Abstract

Sera from a sample of children aged 3 months to 6 years and from cord blood were tested in an indirect immunofluorescence assay (IFA) for reactivity to human herpesviruses 6 (HHV-6) and 7 (HHV-7). HHV-6 seropositivity values rose from 19% to 79.3% in the first 18 months of life, while HHV-7 seroprevalence reached a similar value (75.9%) in children aged 3-6 years. These results show that HHV-7, like HHV-6, is a prevalent virus in infancy. In cord blood sera, assayed to study infant humoral situation at birth, similar values for the two viruses (78.9% for HHV-6 and 76.3% for HHV-7) were found. HHV-6 and HHV-7 IgG antibody affinity to the corresponding antigens was assessed by the end point antibody titration in the presence and absence of urea 8M. This test distinguishes antibodies of recent (low affinity) or past (high affinity) production. Together, the data on seroprevalence and antibody affinity suggest that HHV-6 primary infection generally precedes that by HHV-7. These results are discussed in the light of a different pathogenetic role of the two viruses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8673847

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  8 in total

1.  Identification and analysis of a lytic-phase origin of DNA replication in human herpesvirus 7.

Authors:  N van Loon; C Dykes; H Deng; G Dominguez; J Nicholas; S Dewhurst
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

2.  Immune reactivity of human sera to the glycoprotein B of human herpesvirus 7.

Authors:  Michael Franti; Jean-Thierry Aubin; Guillemette De Saint-Maur; Haruhiko Kosuge; Koichi Yamanishi; Agnes Gautheret-Dejean; Antoine Garbarg-Chenon; Jean-Marie Huraux; Henri Agut
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 3.  Assessing and restoring adaptive immunity to HSV, VZV, and HHV-6 in solid organ and hematopoietic cell transplant recipients.

Authors:  Madeleine R Heldman; Kaja M Aagaard; Joshua A Hill
Journal:  Clin Microbiol Infect       Date:  2022-02-10       Impact factor: 13.310

4.  Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7.

Authors:  C Cermelli; M Vinceti; F Beretti; V Pietrini; G Nacci; P Pietrosemoli; A Bartoletti; D Guidetti; P Sola; M Bergomi; G Vivoli; M Portolani
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

5.  Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study.

Authors:  Leon G Epstein; Shlomo Shinnar; Dale C Hesdorffer; Douglas R Nordli; Aaliyah Hamidullah; Emma K T Benn; John M Pellock; L Matthew Frank; Darrell V Lewis; Solomon L Moshe; Ruth C Shinnar; Shumei Sun
Journal:  Epilepsia       Date:  2012-06-14       Impact factor: 5.864

6.  Human herpesviruses 6 and 7 and central nervous system infection in children.

Authors:  Asad Ansari; Shaobing Li; Mark J Abzug; Adriana Weinberg
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

Review 7.  Advances in the Characterization of the T-Cell Response to Human Herpesvirus-6.

Authors:  Derek J Hanson; Joshua A Hill; David M Koelle
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

8.  Associations Between Salivary Bacteriome Diversity and Salivary Human Herpesvirus Detection in Early Childhood: A Prospective Cohort Study.

Authors:  Freida Blostein; Sydney Foote; Elizabeth Salzman; Daniel W McNeil; Mary L Marazita; Emily T Martin; Betsy Foxman
Journal:  J Pediatric Infect Dis Soc       Date:  2021-09-23       Impact factor: 5.235

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.